Galectin Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GALT and other ETFs, options, and stocks.

About GALT

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. 

CEO
Joel Lewis
CEOJoel Lewis
Employees
15
Employees15
Headquarters
Norcross, Georgia
HeadquartersNorcross, Georgia
Founded
2000
Founded2000
Employees
15
Employees15

GALT Key Statistics

Market cap
81.82M
Market cap81.82M
Price-Earnings ratio
-1.77
Price-Earnings ratio-1.77
Dividend yield
Dividend yield
Average volume
195.03K
Average volume195.03K
High today
$1.34
High today$1.34
Low today
$1.21
Low today$1.21
Open price
$1.30
Open price$1.30
Volume
288.28K
Volume288.28K
52 Week high
$3.28
52 Week high$3.28
52 Week low
$0.726
52 Week low$0.726

People also own

Based on the portfolios of people who own GALT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.